Vamil Divan
Stock Analyst at Guggenheim
(4.84)
# 419
Out of 5,022 analysts
942
Total ratings
58.9%
Success rate
14.5%
Average return
Main Sectors:
Stocks Rated by Vamil Divan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| JBIO Jade Biosciences | Reiterated: Buy | $47 | $13.39 | +251.01% | 10 | Oct 1, 2026 | |
| ENTX Entera Bio | Initiated Coverage: Buy | $11 | $2.87 | +283.28% | 1 | Sep 24, 2026 | |
| TVTX Travere Therapeutics | Reiterated: Buy | $75 → $89 | $56.54 | +57.41% | 31 | Sep 23, 2026 | |
| MRK Merck & Co. | Reiterated: Buy | $146 → $170 | $143.38 | +18.57% | 52 | Sep 8, 2026 | |
| ELOX Eloxx Pharmaceuticals | Reiterated: Buy | $43 | $15.99 | +168.92% | 2 | Aug 23, 2026 | |
| STO: VICO Vicore Pharma Holding AB (publ) | Reiterated: Buy | kr 38.00 | kr 9.31 | +308.16% | 3 | Aug 21, 2026 | |
| CALC CalciMedica | Initiated Coverage: Buy | $9 | $1.67 | +438.92% | 1 | Aug 20, 2026 | |
| SVRA Savara | Reiterated: Buy | $11 | $4.84 | +127.27% | 11 | Aug 20, 2026 | |
| ASMB Assembly Biosciences | Reiterated: Buy | $43 | $22.34 | +92.48% | 13 | Aug 16, 2026 | |
| VERA Vera Therapeutics | Reiterated: Buy | $76 | $29.86 | +154.52% | 16 | Aug 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $11 | $5.75 | +91.30% | 10 | Aug 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $37 → $25 | $4.27 | +485.48% | 9 | Aug 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $343 → $388 | $404.14 | -3.99% | 9 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $124 → $119 | $72.21 | +64.81% | 22 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $207 → $205 | $109.11 | +87.88% | 19 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $35 → $31 | $27.76 | +11.67% | 119 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $270 → $287 | $257.15 | +11.61% | 55 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $261 → $288 | $260.23 | +10.67% | 130 | Aug 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5 → $3 | $5.26 | -42.97% | 5 | Jul 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $15 | $11.09 | +35.26% | 5 | Jun 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 | $2.45 | +226.53% | 9 | Mar 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 → $7 | $1.68 | n/a | 2 | Jul 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $11.05 | n/a | 4 | May 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | €9.00 | €9.01 | n/a | 1 | Mar 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $10.74 | n/a | 3 | May 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $50 → $26 | $3.62 | n/a | 6 | Jun 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.000001 | n/a | 13 | Jul 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $90.11 | n/a | 5 | Jul 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1,146.83 | n/a | 95 | Jul 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $9.10 | n/a | 7 | Jul 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $49 | $178.00 | n/a | 15 | Jun 27, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $15 | $7.14 | n/a | 31 | Jun 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $27 | $19.94 | n/a | 20 | Jun 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $36 | $41.63 | n/a | 72 | May 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 → $10 | $1.84 | n/a | 11 | May 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $52 | $107.99 | n/a | 1 | May 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $738 | $732.72 | n/a | 1 | May 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $6 | $35.56 | n/a | 1 | May 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $136 | $39.82 | n/a | 1 | May 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $265 | $502.35 | n/a | 1 | May 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $95 | $143.10 | n/a | 30 | May 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $58 | $25.18 | n/a | 4 | Sep 21, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $37 | $33.45 | n/a | 1 | May 7, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | n/a | $3.67 | n/a | 3 | Jul 10, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $1.09 | n/a | 2 | Jul 10, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $59 → $55 | $60.89 | n/a | 45 | May 29, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | n/a | $29.00 | n/a | 10 | Dec 13, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $19 | $85.62 | n/a | 1 | Nov 27, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | n/a | $10.86 | n/a | 6 | Aug 23, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $312 → $322 | $221.79 | n/a | 2 | Aug 2, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $29 | $0.74 | n/a | 1 | Oct 26, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $35 → $30 | $4.31 | n/a | 6 | Feb 4, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $198 → $230 | $269.09 | n/a | 7 | Jan 28, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $144.85 | n/a | 1 | Apr 14, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $48 | $167.77 | n/a | 1 | Mar 5, 2013 |
Jade Biosciences
Oct 1, 2026
Reiterated: Buy
Price Target: $47
Current: $13.39
Upside: +251.01%
Entera Bio
Sep 24, 2026
Initiated Coverage: Buy
Price Target: $11
Current: $2.87
Upside: +283.28%
Travere Therapeutics
Sep 23, 2026
Reiterated: Buy
Price Target: $75 → $89
Current: $56.54
Upside: +57.41%
Merck & Co.
Sep 8, 2026
Reiterated: Buy
Price Target: $146 → $170
Current: $143.38
Upside: +18.57%
Eloxx Pharmaceuticals
Aug 23, 2026
Reiterated: Buy
Price Target: $43
Current: $15.99
Upside: +168.92%
Vicore Pharma Holding AB (publ)
Aug 21, 2026
Reiterated: Buy
Price Target: kr 38.00
Current: kr 9.31
Upside: +308.16%
CalciMedica
Aug 20, 2026
Initiated Coverage: Buy
Price Target: $9
Current: $1.67
Upside: +438.92%
Savara
Aug 20, 2026
Reiterated: Buy
Price Target: $11
Current: $4.84
Upside: +127.27%
Assembly Biosciences
Aug 16, 2026
Reiterated: Buy
Price Target: $43
Current: $22.34
Upside: +92.48%
Vera Therapeutics
Aug 14, 2026
Reiterated: Buy
Price Target: $76
Current: $29.86
Upside: +154.52%
Aug 13, 2026
Reiterated: Buy
Price Target: $11
Current: $5.75
Upside: +91.30%
Aug 12, 2026
Reiterated: Buy
Price Target: $37 → $25
Current: $4.27
Upside: +485.48%
Aug 7, 2026
Reiterated: Hold
Price Target: $343 → $388
Current: $404.14
Upside: -3.99%
Aug 7, 2026
Reiterated: Buy
Price Target: $124 → $119
Current: $72.21
Upside: +64.81%
Aug 6, 2026
Reiterated: Buy
Price Target: $207 → $205
Current: $109.11
Upside: +87.88%
Aug 6, 2026
Reiterated: Buy
Price Target: $35 → $31
Current: $27.76
Upside: +11.67%
Aug 5, 2026
Reiterated: Buy
Price Target: $270 → $287
Current: $257.15
Upside: +11.61%
Aug 3, 2026
Reiterated: Buy
Price Target: $261 → $288
Current: $260.23
Upside: +10.67%
Jul 1, 2026
Reiterated: Buy
Price Target: $5 → $3
Current: $5.26
Upside: -42.97%
Jun 25, 2026
Reiterated: Buy
Price Target: $15
Current: $11.09
Upside: +35.26%
Mar 20, 2026
Reiterated: Buy
Price Target: $8
Current: $2.45
Upside: +226.53%
Jul 13, 2025
Reiterated: Buy
Price Target: $6 → $7
Current: $1.68
Upside: n/a
May 29, 2025
Reiterated: Hold
Price Target: n/a
Current: $11.05
Upside: n/a
Mar 31, 2025
Reiterated: Buy
Price Target: €9.00
Current: €9.01
Upside: n/a
May 6, 2024
Reiterated: Hold
Price Target: n/a
Current: $10.74
Upside: n/a
Jun 15, 2023
Reiterated: Buy
Price Target: $50 → $26
Current: $3.62
Upside: n/a
Jul 22, 2022
Rated: Hold
Price Target: n/a
Current: $0.000001
Upside: n/a
Jul 22, 2022
Rated: Hold
Price Target: n/a
Current: $90.11
Upside: n/a
Jul 22, 2022
Rated: Hold
Price Target: n/a
Current: $1,146.83
Upside: n/a
Jul 22, 2022
Rated: Hold
Price Target: n/a
Current: $9.10
Upside: n/a
Jun 27, 2022
Reiterated: Buy
Price Target: $49
Current: $178.00
Upside: n/a
Jun 21, 2022
Reiterated: Buy
Price Target: $15
Current: $7.14
Upside: n/a
Jun 17, 2022
Rated: Hold
Price Target: $27
Current: $19.94
Upside: n/a
May 24, 2022
Reiterated: Buy
Price Target: $36
Current: $41.63
Upside: n/a
May 24, 2022
Reiterated: Buy
Price Target: $20 → $10
Current: $1.84
Upside: n/a
May 22, 2022
Initiated Coverage: Buy
Price Target: $52
Current: $107.99
Upside: n/a
May 22, 2022
Initiated Coverage: Buy
Price Target: $738
Current: $732.72
Upside: n/a
May 22, 2022
Initiated Coverage: Buy
Price Target: $6
Current: $35.56
Upside: n/a
May 22, 2022
Initiated Coverage: Buy
Price Target: $136
Current: $39.82
Upside: n/a
May 22, 2022
Initiated Coverage: Hold
Price Target: $265
Current: $502.35
Upside: n/a
May 4, 2022
Reiterated: Hold
Price Target: $95
Current: $143.10
Upside: n/a
Sep 21, 2021
Reiterated: Buy
Price Target: $58
Current: $25.18
Upside: n/a
May 7, 2021
Reiterated: Buy
Price Target: $37
Current: $33.45
Upside: n/a
Jul 10, 2019
Initiated Coverage: Hold
Price Target: n/a
Current: $3.67
Upside: n/a
Jul 10, 2019
Initiated Coverage: Buy
Price Target: n/a
Current: $1.09
Upside: n/a
May 29, 2019
Reiterated: Hold
Price Target: $59 → $55
Current: $60.89
Upside: n/a
Dec 13, 2018
Upgraded: Buy
Price Target: n/a
Current: $29.00
Upside: n/a
Nov 27, 2017
Initiated Coverage: Buy
Price Target: $19
Current: $85.62
Upside: n/a
Aug 23, 2017
Upgraded: Hold
Price Target: n/a
Current: $10.86
Upside: n/a
Aug 2, 2016
Reiterated: Hold
Price Target: $312 → $322
Current: $221.79
Upside: n/a
Oct 26, 2015
Rated: Buy
Price Target: $29
Current: $0.74
Upside: n/a
Feb 4, 2015
Downgraded: Sell
Price Target: $35 → $30
Current: $4.31
Upside: n/a
Jan 28, 2015
Reiterated: Buy
Price Target: $198 → $230
Current: $269.09
Upside: n/a
Apr 14, 2014
Reiterated: Buy
Price Target: n/a
Current: $144.85
Upside: n/a
Mar 5, 2013
Initiated Coverage: Buy
Price Target: $48
Current: $167.77
Upside: n/a